AU2002300997A1 - Myoblast therapy for mammalian diseases - Google Patents

Myoblast therapy for mammalian diseases

Info

Publication number
AU2002300997A1
AU2002300997A1 AU2002300997A AU2002300997A AU2002300997A1 AU 2002300997 A1 AU2002300997 A1 AU 2002300997A1 AU 2002300997 A AU2002300997 A AU 2002300997A AU 2002300997 A AU2002300997 A AU 2002300997A AU 2002300997 A1 AU2002300997 A1 AU 2002300997A1
Authority
AU
Australia
Prior art keywords
mammalian diseases
myoblast therapy
myoblast
therapy
mammalian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002300997A
Inventor
Peter K. Law
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002300997A1 publication Critical patent/AU2002300997A1/en
Abandoned legal-status Critical Current

Links

AU2002300997A 1994-12-13 2002-09-12 Myoblast therapy for mammalian diseases Abandoned AU2002300997A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US354944 1994-12-13
US477377 1995-06-07

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU58311/99A Division AU748997B2 (en) 1994-12-13 1999-11-05 Myoblast therapy for mammalian diseases

Publications (1)

Publication Number Publication Date
AU2002300997A1 true AU2002300997A1 (en) 2003-02-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP0743820A4 (en) Myoblast therapy for mammalian diseases
AU5268696A (en) Novel compounds and methods for therapy
AU2552795A (en) Safe vectors for gene therapy
AU2805195A (en) Therapeutic compounds
AU7867994A (en) Hemofiltration of mediator-related diseases
AU3972893A (en) Gene therapy using the intestine
AU1967395A (en) Process for the preparation of hydrogenated rubber
AU7019494A (en) Genetic therapy for cardiovascular disease
AU6011496A (en) Improved pharmaceutical compositions for gene therapy
AU3663495A (en) Method apparatus for administering clinical trial material
AUPO665397A0 (en) Novel therapy for constipation
AU2003495A (en) Sub-compact blood culture apparatus
AU2734895A (en) Process for the preparation of 3-aryluracils
AU2762395A (en) Process for the preparation of azanoradamantane benzamides
AU3596797A (en) Methods for the treatment of apolipoprotein e related diseases
AU5315096A (en) 19-oxygenated steroids as therapeutic agents
AU670864B2 (en) Magnetic therapeutic apparatus
AU3574793A (en) Remedy for airway diseases
AU5486396A (en) Process for the preparation of spiroindolines
AU7096496A (en) Process for the preparation of 4-methylenepiperidines
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AU3783097A (en) Process for the preparation of hexanitrohexaazaisowurtzitanes
AU697487B2 (en) Therapeutic agent for ischemic diseases
AUPM885894A0 (en) Therapeutic molecules
AU2002300997A1 (en) Myoblast therapy for mammalian diseases